Dr. Annie Luetkemeyer moves with the quiet urgency of someone who has spent her career on the front lines of infectious disease. When I photographed her on May 7, 2021, at San Francisco General Hospital’s famed Ward 86, the first dedicated HIV/AIDS clinic in the country, there was a weight to the moment. The world was still deep in the throes of the COVID-19 pandemic, and much of our conversation revolved around the parallels between these two public health crises: the fear, the stigma, the desperate need for science to catch up to suffering.
Ward 86 is more than a clinic; it is a living monument to the history of modern medicine. The walls carry the echoes of countless lives touched by the early days of the HIV/AIDS epidemic when San Francisco was ground zero for a new and terrifying disease. Annie, an infectious disease specialist at UCSF, has spent years working in the trenches of this epidemic, studying the intersection of HIV, tuberculosis, and viral hepatitis. Her work extends beyond the Bay Area to global health efforts, with a particular focus on expanding access to treatment for the most vulnerable populations.
And then came COVID. As the pandemic unfolded, she found herself at the center of the response, pivoting from decades of HIV research to lead clinical trials on emerging COVID treatments. She was one of the principal investigators on studies that examined the efficacy of remdesivir and other antiviral therapies, helping to shape the standard of care during the most uncertain days of the crisis. For someone whose career had been spent battling one virus, the arrival of another felt eerily familiar.
Despite the gravity of her work, Annie exudes warmth and humor. She speaks about the science of pandemics with the ease of someone who has spent years making the complicated understandable. And then there’s her family, while she has made a name for herself in medicine, her sister, Julie Bowen, is famous in a different realm: Hollywood, best known for her role on Modern Family.
But there is something fitting about it, too. Both sisters, in their own way, have shaped the cultural landscape, one through entertainment, the other through the slow, unglamorous, deeply necessary work of fighting disease. Annie’s world is not one of scripts and cameras but of clinical trials, viral load counts, and the relentless pursuit of better treatments.
Even as COVID dominated the headlines in 2021, she remained deeply committed to her HIV research. She spoke about the ongoing battle against the virus that had defined much of her career, the need for long-acting injectable treatments, the continuing disparities in care, the lessons learned from one pandemic that could be applied to another. For her, these diseases are not separate, they are threads in the same fabric of global health, shaped by policy, access, and the will to act.
Standing in Ward 86 that day, I couldn’t help but think about the generations of physicians, researchers, and activists who had passed through those halls, fighting to turn the tide of an epidemic that once seemed unstoppable. Annie Luetkemeyer is part of that lineage. She is not just studying diseases; she is shaping the future of how we fight them. And as the world looks ahead to the next pandemic, the next public health crisis, it is people like her, steady, brilliant, and tireless, who will be leading the charge.
